Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 15-Aug-23 5:58 PM View:  | Jazz Pharmaceuticals, Inc. (JAZZ) | 14-Aug-23 | Sale | 1,241 | $138.16 | $171,454.00 | (8%) 14.95K to 13.71K | |
| 15-Aug-23 5:58 PM View: | Jazz Pharmaceuticals, Inc. (JAZZ) | 11-Aug-23 | Grant | 3,075 | -- | -- | 26% 11.87K to 14.95K | |
| 09-Jun-23 4:15 PM View: | Cerevel Therapeutics Holdin... (CERE) | 07-Jun-23 | Grant | 3,282 | -- | -- | 8% 42.81K to 46.09K | |
| 09-Aug-22 6:38 PM View: | Jazz Pharmaceuticals, Inc. (JAZZ) | 08-Aug-22 | Sale | 1,089 | $152.32 | $165,877.00 | (8%) 12.96K to 11.87K | |
| 09-Aug-22 6:38 PM View: | Jazz Pharmaceuticals, Inc. (JAZZ) | 05-Aug-22 | Grant | 2,561 | -- | -- | 25% 10.4K to 12.96K | |
| 09-Aug-22 6:38 PM View: | Jazz Pharmaceuticals, Inc. (JAZZ) | 05-Aug-22 | Option Exercise | 8,000 | $55.28 | $442,240.00 | 62% 12.96K to 20.96K | |
| 09-Aug-22 6:38 PM View: | Jazz Pharmaceuticals, Inc. (JAZZ) | 05-Aug-22 | Option Sale | 8,000 | $155.87 | $1,246,920.00 | (38%) 20.96K to 12.96K | |
| 06-Jan-22 4:31 PM View: | Cerevel Therapeutics Holdin... (CERE) | 04-Jan-22 | Option Exercise | 14,270 | -- | -- | 50% 28.54K to 42.81K | |
| 08-Dec-21 4:16 PM View: | Aptinyx Inc. (APTX) | 06-Dec-21 | Market Purchase | 100,000 | $2.23 | $223,000.00 | 8% 1.26M to 1.36M | 2% |
| 10-Aug-21 5:38 PM View: | Jazz Pharmaceuticals, Inc. (JAZZ) | 06-Aug-21 | Market Sale | 1,306 | $147.96 | $193,236.00 | (11%) 11.71K to 10.4K | (2%) |
| 02-Aug-21 6:25 PM View: | Jazz Pharmaceuticals, Inc. (JAZZ) | 29-Jul-21 | Grant | 2,246 | -- | -- | 24% 9.46K to 11.71K | |
| 19-May-21 6:46 PM View: | Aptinyx Inc. (APTX) | 17-May-21 | Payment of Exercise | 127,274 | $2.53 | $322,003.00 | (17%) 742.54K to 615.26K | |
| 19-May-21 6:46 PM View: | Aptinyx Inc. (APTX) | 17-May-21 | Option Exercise | 380,000 | -- | -- | 105% 362.54K to 742.54K | |
| 06-Jan-21 4:26 PM View: | Cerevel Therapeutics Holdin... (CERE) | 04-Jan-21 | Option Exercise | 14,270 | -- | -- | 100% 14.27K to 28.54K | |
| 10-Aug-20 4:50 PM View: | Jazz Pharmaceuticals, Inc. (JAZZ) | 07-Aug-20 | Market Sale | 931 | $125.87 | $117,186.00 | (9%) 10.39K to 9.46K | (25%) |
| 10-Aug-20 4:50 PM View: | Jazz Pharmaceuticals, Inc. (JAZZ) | 06-Aug-20 | Grant | 2,705 | -- | -- | 35% 7.68K to 10.39K | |
| 14-Jan-20 4:23 PM View: | Aptinyx Inc. (APTX) | 10-Jan-20 | Market Purchase | 35,000 | $3.00 | $105,000.00 | 4% 968.15K to 1.0M | 21% |
| 12-Aug-19 5:32 PM View: | Jazz Pharmaceuticals, Inc. (JAZZ) | 09-Aug-19 | Market Sale | 726 | $135.65 | $98,481.70 | (9%) 8.41K to 7.68K | (16%) |
| 12-Aug-19 5:32 PM View: | Jazz Pharmaceuticals, Inc. (JAZZ) | 08-Aug-19 | Grant | 1,920 | -- | -- | 30% 6.49K to 8.41K | |
| 15-Nov-18 7:10 PM View: | Eton Pharmaceuticals, Inc. (ETON) | 15-Nov-18 | Purchase | 5,000 | $6.00 | $30,000.00 | 9% 54.74K to 59.74K | |
| 14-Nov-18 4:16 PM View: | Aptinyx Inc. (APTX) | 12-Nov-18 | Option Exercise | 38,563 | $2.59 | $99,878.20 | 4% 929.58K to 968.15K | |
| 13-Aug-18 7:57 PM View: | Jazz Pharmaceuticals, Inc. (JAZZ) | 10-Aug-18 | Market Sale | 660 | $176.61 | $116,563.00 | (9%) 7.15K to 6.49K | 11% |
| 13-Aug-18 7:57 PM View: | Jazz Pharmaceuticals, Inc. (JAZZ) | 09-Aug-18 | Grant | 1,495 | -- | -- | 26% 5.66K to 7.15K | |
| 26-Jun-18 4:44 PM View: | Aptinyx Inc. (APTX) | 25-Jun-18 | Conversion | 116,481 | -- | -- | 14% 807.99K to 924.47K | |
| 26-Jun-18 4:44 PM View: | Aptinyx Inc. (APTX) | 25-Jun-18 | Conversion | 2,718 | -- | -- | < 1% 924.47K to 927.18K | |
| 26-Jun-18 4:44 PM View: | Aptinyx Inc. (APTX) | 25-Jun-18 | Purchase | 2,400 | $16.00 | $38,400.00 | < 1% 927.18K to 929.58K | |
| 14-Aug-17 5:27 PM View: | Jazz Pharmaceuticals, Inc. (JAZZ) | 11-Aug-17 | Market Sale | 662 | $142.37 | $94,247.60 | (10%) 6.32K to 5.66K | (10%) |
| 14-Aug-17 5:27 PM View: | Jazz Pharmaceuticals, Inc. (JAZZ) | 10-Aug-17 | Grant | 1,365 | -- | -- | 28% 4.95K to 6.32K | |
| 16-Feb-17 2:16 PM View: | Ariad Pharmaceuticals Inc. (ARIA) | 16-Feb-17 | Disposition | 139,867 | -- | -- | (100%) 139.87K to 0 | |
| 01-Feb-17 4:55 PM View: | Ariad Pharmaceuticals Inc. (ARIA) | 31-Jan-17 | Grant | 18,008 | -- | -- | 15% 121.86K to 139.87K | |
| 17-Aug-16 5:35 PM View: | Jazz Pharmaceuticals, Inc. (JAZZ) | 15-Aug-16 | Market Sale | 633 | $136.45 | $86,372.90 | (11%) 5.59K to 4.95K | (15%) |
| 15-Aug-16 6:08 PM View: | Jazz Pharmaceuticals, Inc. (JAZZ) | 11-Aug-16 | Grant | 1,365 | -- | -- | 32% 4.22K to 5.59K | |
| 17-May-16 5:39 PM View: | Jazz Pharmaceuticals, Inc. (JAZZ) | 16-May-16 | Market Sale | 644 | $145.20 | $93,508.80 | (13%) 4.87K to 4.22K | (8%) |
| 03-Feb-16 4:47 PM View: | Ariad Pharmaceuticals Inc. (ARIA) | 01-Feb-16 | Grant | 12,500 | -- | -- | 11% 109.36K to 121.86K | |
| 11-Aug-15 5:41 PM View: | Jazz Pharmaceuticals, Inc. (JAZZ) | 10-Aug-15 | Market Sale | 801 | $180.00 | $144,178.00 | (14%) 5.67K to 4.87K | 13% |
| 11-Aug-15 5:41 PM View: | Jazz Pharmaceuticals, Inc. (JAZZ) | 07-Aug-15 | Grant | 1,310 | -- | -- | 30% 4.36K to 5.67K | |
| 14-May-15 8:12 PM View: | Jazz Pharmaceuticals, Inc. (JAZZ) | 12-May-15 | Market Sale | 650 | $173.86 | $113,010.00 | (13%) 5.01K to 4.36K | 10% |
| 04-Feb-15 4:36 PM View: | Ariad Pharmaceuticals Inc. (ARIA) | 31-Jan-15 | Grant | 12,500 | -- | -- | 13% 96.86K to 109.36K | |
| 11-Aug-14 7:35 PM View: | Jazz Pharmaceuticals, Inc. (JAZZ) | 07-Aug-14 | Grant | 1,650 | -- | -- | 49% 3.36K to 5.01K | |
| 29-May-14 7:27 PM View: | Jazz Pharmaceuticals, Inc. (JAZZ) | 28-May-14 | Market Sale | 644 | $142.49 | $91,763.60 | (16%) 4.0K to 3.36K | (10%) |
| 04-Feb-14 6:10 PM View: | Ariad Pharmaceuticals Inc. (ARIA) | 31-Jan-14 | Grant | 12,500 | -- | -- | 15% 84.36K to 96.86K | |
| 13-May-13 6:25 PM View: | Jazz Pharmaceuticals, Inc. (JAZZ) | 09-May-13 | Grant | 4,000 | -- | -- | 100% 0 to 4.0K | |
| 04-Feb-13 4:46 PM View: | Ariad Pharmaceuticals Inc. (ARIA) | 31-Jan-13 | Grant | 14,000 | -- | -- | 20% 70.36K to 84.36K | |
| 18-Jan-13 4:28 PM View: | Baxter International Inc. (BAX) | 16-Jan-13 | Grant | 5,799 | -- | -- | 11% 52.81K to 58.61K | |
| 18-Jan-13 4:28 PM View: | Baxter International Inc. (BAX) | 16-Jan-13 | Payment of Exercise | 1,925 | $66.52 | $128,051.00 | (3%) 58.61K to 56.69K | 32% |
| 06-Aug-12 5:10 PM View: | Baxter International Inc. (BAX) | 03-Aug-12 | Option Exercise | 70,125 | $38.35 | $2,689,290.00 | 133% 52.81K to 122.94K | |
| 06-Aug-12 5:10 PM View: | Baxter International Inc. (BAX) | 03-Aug-12 | Market Option Sale | 70,125 | $58.99 | $4,136,670.00 | (57%) 122.94K to 52.81K | 25% |
| 31-Jan-12 4:35 PM View: | Ariad Pharmaceuticals Inc. (ARIA) | 31-Jan-12 | Grant | 18,359 | -- | -- | 35% 52.0K to 70.36K | |
| 02-May-11 4:44 PM View: | Ariad Pharmaceuticals Inc. (ARIA) | 28-Apr-11 | Grant | 15,000 | -- | -- | 41% 37.0K to 52.0K | |
| 21-Jan-11 5:50 PM View: | Baxter International Inc. (BAX) | 19-Jan-11 | Grant | 3,302 | -- | -- | 7% 49.76K to 53.07K |